Press play.

As you can see, lung cancer screening with CT is about as clearcut as prostate cancer screening with PSA. So in a similar vein, some think we should leave the decision for lung cancer screening in the hands of patients. This prospective trial randomized 516 recent and current clients of a quit-line to an educational video on the potential benefit and harm of CT screening versus standard educational material with a two-page brochure. Those with the video had over 2x the odds of feeling prepared to make an informed decision. TBL: If you have trouble interpreting the findings of lung cancer screening trials, you can use creative tools to help your patients make decisions for themselves. | Volk, JAMA Netw Open 2020